HIGHLIGHTS
- who: Oliver Madge et al. from the Ambulatory Assessment Unit, Oxford University Hospitals NHS Foundation Trust, Oxford , DU, UK have published the research: The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis, in the Journal: (JOURNAL) of 28/Dec/2021
- what: Whilst this study provided novel and important data regarding the impact of COVID-19 upon patient outcomes in PDAC, there were some limitations.
- how: The mortality data were analysed using standard methods of Kaplan-Meier survival analysis to calculate the median survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.